The Promise of State-of-the-Art Sequencing Technologies for Cancer Screening
Circulating tumor DNA sequencing technologies are tackling the challenges of early cancer detection.
Circulating tumor DNA sequencing technologies are tackling the challenges of early cancer detection.
A new test targeting changes in serum proteins can detect breast cancer up to two years before the condition would normally be diagnosed.
Team creates a mass spectrometry-based blood lipid test that, when combined with AI, identifies early signs of the disease.
A post-surgery liquid biopsy test capable of detecting ctDNA could eliminate the need for chemotherapy for some stage II cancer patients.
Research team’s prototype test is easier to use than current methods and can detect cancer markers within 4.5 hours.